| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 06/02/1993 | EP0543938A1 Inhibition of influenza virus type a, ann arbor strain h2n2 by antisense oligonucleotides |
| 06/02/1993 | EP0543902A1 Use of metalloporphyrins to potentiate aids therapy |
| 06/02/1993 | EP0543819A1 Cephalosporin compounds and processes for preparation thereof |
| 06/02/1993 | EP0533825A4 Ether lipid-nucleoside covalent conjugates |
| 06/02/1993 | CN1021052C 8-alkoxyquinolonecar boxylic acid and salts thereof excellent in selective toxicity and process of preparing same |
| 06/01/1993 | US5216168 2- and 3- amino and azido derivatives of 1,5-iminosugars |
| 06/01/1993 | US5216142 Anti-virals |
| 06/01/1993 | US5215983 Carbapenem compounds |
| 06/01/1993 | US5215982 Cephem compounds |
| 06/01/1993 | CA1318615C Radiohalogenated compounds for site specific labeling |
| 06/01/1993 | CA1318601C Use of tetronasin and analogs against swine dysentery |
| 06/01/1993 | CA1318599C Pharmaceutical compositions containing dyclonine hc1 and phenol |
| 05/30/1993 | WO1993011124A1 Trisubstituted pyrrole derivatives having antifungine activity, a process for their preparation and related pharmaceutical compositions |
| 05/30/1993 | CA2100666A1 Trisubstituted pyrrole derivatives having antifungine activity, a process for their preparation and related pharmaceutical compositions |
| 05/28/1993 | CA2084018A1 Alkylaminoalkylpyrrolidinylthiocarbapenem derivatives |
| 05/28/1993 | CA2083798A1 5,6-dihydro-dibenz(b,e) azepine-6,11-dione-11-oximes |
| 05/28/1993 | CA2083794A1 6-thiono-5,6-dihydro-dibenz(b,e) azepin-11-one-11-oximes |
| 05/28/1993 | CA2083771A1 Aminoalkyl-substituted 5, 6-dihydro-dibenz (b,e) azepine-6, 11-dione-11-oximes |
| 05/27/1993 | WO1993010239A2 Hepatitis-c virus testing |
| 05/27/1993 | WO1993010237A1 Recombinant vaccine against lyme disease |
| 05/27/1993 | WO1993010153A1 Bactericidal product, pharmaceutical composition containing same and food additive |
| 05/27/1993 | WO1993010142A1 New lupane derivatives, preparation thereof and pharmaceutical compositions containing them |
| 05/27/1993 | WO1993010137A1 2'-deoxy-2'-fluorocoformycin and stereoisomers thereof |
| 05/27/1993 | WO1993010123A1 Process for the preparation of cephem derivatives |
| 05/27/1993 | WO1993009813A1 Therapeutic compounds |
| 05/27/1993 | WO1993009812A1 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES |
| 05/27/1993 | WO1993009811A1 TYPE I AND TYPE II SURFACE ANTIGENS ASSOCIATED WITH $i(STAPHYLOCOCCUS EPIDERMIDIS) |
| 05/27/1993 | WO1993009809A1 Pasteurella multocida toxoid vaccines |
| 05/27/1993 | WO1993009805A1 Polar lipid composition of plant origin |
| 05/27/1993 | WO1993009793A1 Lactobacillus and skim milk compositions and methods for preventing microbial urogenital infections |
| 05/27/1993 | WO1993009786A1 Phosphorylated flavanoids in the treatment of viral diseases |
| 05/27/1993 | WO1993009770A1 Bactericidal pharmaceutical composition containing chlorhexidine and eugenol |
| 05/27/1993 | WO1993009764A1 Combined virustatic antimediator (covam) treatment of common colds |
| 05/27/1993 | CA2378820A1 Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of t-lymphocytes |
| 05/27/1993 | CA2123709A1 Lactobacillus and skim milk compositions and methods for preventing microbial urogenital infections |
| 05/27/1993 | CA2123587A1 Bactericide product; pharmaceutical composition and food additive containing the same |
| 05/27/1993 | CA2123585A1 Polar lipidic composition from plants |
| 05/27/1993 | CA2123320A1 Pasteurella multocida toxoid vaccines |
| 05/27/1993 | CA2123121A1 Recombinant vaccine against lyme disease |
| 05/27/1993 | CA2122719A1 Combined virustatic antimediator (covam) treatment of common colds |
| 05/27/1993 | CA2122641A1 Phosphorylated flavanoids in the treatment of viral diseases |
| 05/27/1993 | CA2121692A1 New lupane derivatives, preparation thereof and pharmaceutical compositions containing them |
| 05/27/1993 | CA2083345A1 Cephalosporin derivatives |
| 05/26/1993 | EP0543555A1 Phosphorylated flavanoids in the treatment of viral diseases |
| 05/26/1993 | EP0543521A2 High dosage topical forms of collagenase |
| 05/26/1993 | EP0543516A1 Hapalindole alkaloids as antifungal and antitumor agents |
| 05/26/1993 | EP0543201A2 Alkoxylated phenyl and coumarin derivatives, their production and use for the manufacture of medicaments |
| 05/26/1993 | EP0543004A1 Purine base modified 2'-deoxyribonucleosides, use in triplex forming oligonucleotides and process for preparing the same |
| 05/26/1993 | EP0542998A1 Vaccine and treatment method of human immunodeficiency virus infection |
| 05/26/1993 | EP0542977A1 Oral composition based on an antibiotic material and clay |
| 05/26/1993 | EP0542949A1 Hepatitis a virus strain, method for the isolation of said virus strains and hepatitis a vaccines |
| 05/26/1993 | EP0542841A1 New synergistic composition of 2-(2-bromo-2-nitroethenyl) furan and 2-bromo-2-nitropropane-1,3-diol and uses thereof. |
| 05/26/1993 | EP0542822A1 Viral (hiv) growth inhibition |
| 05/26/1993 | EP0542795A1 Tnf inhibitors |
| 05/26/1993 | EP0542756A1 Method of introducing a peptide into the cytosol |
| 05/26/1993 | EP0540686A4 2'-fluorofuranosyl derivatives and novel method of preparing 2'-fluoropyrimidine and 2'-fluoropurine nucleosides |
| 05/26/1993 | EP0532530A4 Derivatives of 6-aminooctahydroindolizinetriol |
| 05/26/1993 | CN1020893C Improved process for preparing vinyl ethers |
| 05/26/1993 | CN1020857C Peptides corresponding to antigenic and immunogenic determinants of major nentralizing proteins of rotaviruses |
| 05/25/1993 | US5214067 Fungicidal compositions and method |
| 05/25/1993 | US5214062 Method and composition for treating immune disorders, inflammation and chronic infections |
| 05/25/1993 | US5214053 Thiourea derivatives and antimicrobial agent and antiulcer agent containing the same |
| 05/25/1993 | US5214037 Antibiotic, bactericide |
| 05/25/1993 | US5213804 Localized delivery of antibiotic to tumor via bloodstream, encapsulation in liposome |
| 05/25/1993 | US5213798 Antiviral agent derived from the hull of the kukui nut |
| 05/25/1993 | CA1318457C Partially retro-inverted tuftsin analogues, method for the preparation thereof and pharmaceutical compositions containing them |
| 05/25/1993 | CA1318318C Polycyclic ether antibiotics |
| 05/19/1993 | EP0542681A1 Process for the preparation of carbocyclic nucleosides and its intermediates |
| 05/19/1993 | EP0542630A2 Use of derivatives of amphotericin B as protease inhibitors |
| 05/19/1993 | EP0542622A1 New lupane derivatives, a process for their production and pharmaceutical compositions containing them |
| 05/19/1993 | EP0542468A1 Isothiazolyl compounds and their use as microbicides |
| 05/19/1993 | EP0541753A1 NOVEL HYBRID, SOLUBLE AND UNCLEAVED gp160 VARIANT. |
| 05/19/1993 | EP0541742A1 2',5'-nucleotide analogs as antiviral agents |
| 05/19/1993 | EP0541721A1 Expression of human cmv glycoprotein-h using the baculovirus-insect cell expression system |
| 05/19/1993 | EP0541720A1 Golfomycin derivatives: novel fused ring cyclodecadiyne derivatives |
| 05/19/1993 | EP0541692A1 Herpes simplex virus vp16 vaccines |
| 05/19/1993 | EP0541670A1 Phosphene oxide-terminated allene-ene-yne dna-cleaving, antitumor and antibiotic molecules |
| 05/19/1993 | EP0541597A1 Hexa-n-(o-hydroxybenzyl) neomycin b for inhibiting human retroviruses and for the treatment of aids |
| 05/19/1993 | CN1072172A Novel t-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines |
| 05/19/1993 | CN1072061A Stable antimicrobial dialdehyde composition and methods of use |
| 05/19/1993 | CN1020732C Preparation method for substituted vinylcephalosporins. |
| 05/18/1993 | US5212157 Tetrapeptides as inhibitors of HIV |
| 05/18/1993 | US5211945 Compositions and methods for modulating the effect of tnf and il-1 |
| 05/18/1993 | US5211944 Proanthocyanidin polymers having antiviral activity and methods of obtaining same |
| 05/18/1993 | CA1317900C Antibiotic a 40926 complex and its pure factors pa, pb, a, b, and b |
| 05/15/1993 | WO1993009791A2 Use of amphotericin b derivatives as protease inhibitors |
| 05/15/1993 | CA2099490A1 Use of amphotericin b derivatives as protease inhibitors |
| 05/13/1993 | WO1993009238A1 Feline leukemia virus vaccines |
| 05/13/1993 | WO1993009221A1 Targeted delivery of virus vector to mammalian cells |
| 05/13/1993 | WO1993009132A1 Hiv protease inhibitors containing guanidine |
| 05/13/1993 | WO1993009115A1 Biphenylylquinuclidines, useful as squalene synthetase inhibitors |
| 05/13/1993 | WO1993009114A1 Tri-substituted tetrahydrofuran antifungals |
| 05/13/1993 | WO1993009110A1 Compound dc8118 |
| 05/13/1993 | WO1993009103A1 Substituted aryl- and heteroarylphenyloxazolidinones useful as antibacterial agents |
| 05/13/1993 | WO1993009096A1 Hiv protease inhibitors useful for the treatment of aids |
| 05/13/1993 | WO1993008836A1 Induction of protection against viral infection by synergy between viral proteins and viral peptides |
| 05/13/1993 | WO1993008835A1 Cd8+ cell antiviral factor |
| 05/13/1993 | WO1993008834A1 Vaccine against pathogens of mucosae using liposomes |
| 05/13/1993 | WO1993008816A1 Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof |
| 05/13/1993 | WO1993008815A1 Pharmaceutical dipeptide compositions and methods of use thereof |